GO:0002127 tRNA wobble base cytosine methylation: Epitranscriptomic Regulation, Genes, Functions and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0002127 describes the post-transcriptional methylation of cytosine at position 34 (the wobble position) of tRNA anticodons, forming 5-methylcytosine (m5C).
The human enzyme NSUN2 catalyzes intron-dependent m5C formation at the first position of the anticodon of pre-tRNA-Leu(CAA), linking splicing and tRNA modification.
Wobble cytosine methylation influences codon-anticodon pairing and translational fidelity, with structural studies using chemical and enzymatic probes revealing anticodon accessibility.
NSUN3-related mitochondrial disease can present with hypertrophic cardiomyopathy, highlighting the clinical importance of wobble base modifications.
Dysregulation of tRNA m5C writers is implicated in cancer, neurodevelopmental disorders, and mitochondrial dysfunction.
CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of GO:0002127 in human cells.

Description

tRNA wobble base cytosine methylation (GO:0002127) is a conserved post-transcriptional RNA modification that installs a methyl group at the C5 position of cytosine 34 in the anticodon loop of transfer RNAs. This modification, abbreviated m5C34, occurs at the wobble position and is critical for fine-tuning codon-anticodon interactions during translation. The reaction is catalyzed by dedicated RNA methyltransferases, with NSUN2 being the principal human enzyme responsible for intron-dependent m5C formation in pre-tRNA-Leu(CAA). Because wobble modifications directly affect decoding efficiency and fidelity, their dysregulation can perturb the proteome and has been linked to human disease. Researchers study GO:0002127 to understand how epitranscriptomic marks shape translation and to explore therapeutic opportunities in cancer, mitochondrial disorders, and neurodevelopmental conditions. Structural and biochemical probes have long been used to map anticodon accessibility and modification status, providing a foundation for modern CRISPR-based functional genomics.

tRNA wobble base cytosine methylation At A Glance

GO ID GO:0002127
GO term tRNA wobble base cytosine methylation
Ontology biological_process
Synonym wobble position m5C biosynthesis
Definition The process in which the base of cytosine at position 34 in the anticodon of a tRNA is post-transcriptionally methylated at the C5 position.
Major function Introduces m5C at the wobble position to modulate codon-anticodon pairing and translational fidelity.
Key enzyme NSUN2 (human tRNA:m5C methyltransferase) catalyzes intron-dependent m5C formation in pre-tRNA-Leu(CAA).
Substrate Cytosine 34 in the anticodon loop of tRNA.
Related disease NSUN3-related mitochondrial disease with hypertrophic cardiomyopathy.

What Is GO:0002127?

GO:0002127 is defined as the biological process in which the cytosine base at position 34 of a tRNA anticodon is post-transcriptionally methylated at the C5 position, yielding 5-methylcytosine (m5C) at the wobble site. This modification occurs on tRNA molecules after transcription and often depends on intron processing for certain tRNA species such as pre-tRNA-Leu(CAA).

Why Is tRNA wobble base cytosine methylation Important in Cell Biology?

GO:0002127 is important because wobble base cytosine methylation directly impacts the speed and accuracy of protein synthesis, and its disruption can alter cellular proteostasis. The modification is essential for proper decoding of leucine codons by tRNA-Leu(CAA), and loss of NSUN2 function affects tRNA stability and translation. Clinically, mutations in the related mitochondrial methyltransferase NSUN3 cause a multisystem disorder that includes hypertrophic cardiomyopathy, underscoring the medical relevance of wobble modifications. Thus, understanding GO:0002127 provides mechanistic insight into translational control and human disease.
Regulates codon-anticodon pairing at the wobble position, influencing translation efficiency.
Required for intron-dependent m5C formation in pre-tRNA-Leu(CAA), linking splicing to tRNA modification.
Modulates tRNA stability and processing, with defects leading to altered tRNA pools.
Implicated in mitochondrial disease: NSUN3-related disorder presents with hypertrophic cardiomyopathy.
Potential role in cancer biology through dysregulated RNA modification writers.
Affects neurodevelopment and metabolic homeostasis via translational control.
Provides a target for epitranscriptomic therapeutics and biomarker discovery.
Enables study of RNA modification crosstalk using chemical and enzymatic probes.

What Happens During tRNA wobble base cytosine methylation?

Substrate recognition and intron dependence
In simple terms: The enzyme first finds the right tRNA and often needs the tRNA to be spliced before it can add the methyl mark.
NSUN2 recognizes pre-tRNA-Leu(CAA) and catalyzes m5C formation in an intron-dependent manner, meaning the presence of the intron is required for efficient methylation at position 34. This step ensures that only properly processed tRNA precursors receive the wobble modification.
Catalytic methyl transfer to cytosine 34
In simple terms: The enzyme attaches a methyl group to the cytosine base at the wobble position.
The methyltransferase transfers a methyl group from S-adenosyl-L-methionine to the C5 position of cytosine 34, generating m5C in the anticodon loop. This chemical modification does not change the base pairing face directly but alters the physical properties of the wobble nucleotide.
Structural consequences for anticodon accessibility
In simple terms: The modification changes how the anticodon loop is exposed, which can affect how it binds to the ribosome and mRNA.
Chemical and enzymatic probes have been used to study the interaction of tRNA with synthetases and to map anticodon accessibility, revealing that modifications at the wobble position influence the conformational flexibility of the anticodon loop. Such structural probing provides insight into how m5C34 modulates decoding.
Impact on translation and codon-anticodon pairing
In simple terms: The methyl mark helps the tRNA read its codon correctly during protein synthesis.
m5C at position 34 fine-tunes the pairing between the tRNA anticodon and mRNA codons, thereby affecting translational fidelity and efficiency. Loss of this modification can lead to mistranslation or reduced translation of specific codons.
Disease-associated dysfunction
In simple terms: When this process goes wrong, it can cause serious health problems, including heart disease.
Mutations in NSUN3, which is involved in mitochondrial tRNA wobble modifications, cause a disorder that can include hypertrophic cardiomyopathy, demonstrating the clinical impact of defective wobble methylation. This highlights the importance of GO:0002127 in human health.

Key Genes Involved in GO:0002127 tRNA wobble base cytosine methylation

The following genes and proteins are central to tRNA wobble base cytosine methylation (GO:0002127) and its regulation.
GeneMajor RoleResearch Relevance
NSUN2Human tRNA:m5C methyltransferase that catalyzes intron-dependent m5C formation at position 34 of pre-tRNA-Leu(CAA)Core writer for GO:0002127; knockout and point mutation models reveal effects on translation and tRNA stability
NSUN3Mitochondrial tRNA methyltransferase associated with wobble modifications; mutations cause NSUN3-related mitochondrial diseaseDisease modeling for hypertrophic cardiomyopathy and mitochondrial dysfunction
NSUN4Mitochondrial rRNA methyltransferase; not directly implicated in GO:0002127 but part of NSUN familyComparative studies of RNA modification enzymes
NSUN5rRNA methyltransferase; not directly implicated in GO:0002127Family-wide functional screens
NSUN6tRNA m5C methyltransferase targeting position 72; distinct from wobble position 34Specificity studies of tRNA modification enzymes
NSUN7Putative RNA methyltransferase with roles in sperm motility; not directly linked to GO:0002127Reproductive biology studies
DNMT2tRNA methyltransferase that methylates C38 in tRNA-Asp; not wobble position 34Cross-talk between tRNA modifications
TRMT2AtRNA m5U methyltransferase; not directly involved in GO:0002127Comparative epitranscriptomics
ALKBH1tRNA demethylase that can reverse m5C modifications; potential eraser for wobble m5CRegulation of m5C dynamics
TET2DNA/RNA demethylase; potential indirect regulator of m5CEpitranscriptomic crosstalk
METTL3m6A writer; not directly involved in GO:0002127General RNA modification studies
FTOm6A demethylase; not directly involved in GO:0002127Obesity and RNA modification links
ELP1Component of Elongator complex that modifies wobble uridines; not cytosine methylationComparative wobble modification studies
ELP3Catalytic subunit of Elongator; modifies wobble uridinesNeuronal development and tRNA modification
CTU1Thiolation of wobble uridines; not cytosine methylationtRNA modification pathway crosstalk
CTU2Thiolation of wobble uridines; not cytosine methylationtRNA modification pathway crosstalk
MTO1Mitochondrial tRNA modification; not directly GO:0002127Mitochondrial translation studies
GTPBP3Mitochondrial tRNA modification; not directly GO:0002127Mitochondrial disease models

How Is tRNA wobble base cytosine methylation Regulated?

The regulation of tRNA wobble base cytosine methylation (GO:0002127) is not fully understood, but evidence indicates that NSUN2-mediated m5C formation is intron-dependent for pre-tRNA-Leu(CAA), linking the process to splicing and tRNA maturation. Additionally, the modification can be reversed by demethylases such as ALKBH1, suggesting dynamic regulation of m5C levels. Disease-associated mutations in NSUN3 affect mitochondrial tRNA modifications, indicating that genetic lesions can disrupt this process. However, specific signaling pathways (e.g., mTOR, ISR) that regulate GO:0002127 have not been definitively established in the provided literature.

tRNA wobble base cytosine methylation and Human Disease

GeneDisease / BiologyPotential Experimental Model
NSUN3NSUN3-related mitochondrial disease with hypertrophic cardiomyopathyKnockout or point-mutation iPSC-derived cardiomyocytes
NSUN2Cancer and neurodevelopmental disordersKnockout and overexpression in cancer cell lines
NSUN2Translational defects and tRNA instabilityKnock-in of catalytic-dead NSUN2 in HEK293T cells
ALKBH1Regulation of m5C dynamicsOverexpression and knockout in neuronal cells
NSUN3Mitochondrial translation dysfunctionPatient-derived fibroblasts and CRISPR-corrected isogenic controls
NSUN3-related mitochondrial disease and hypertrophic cardiomyopathy
Mutations in NSUN3, a mitochondrial tRNA methyltransferase, cause a novel phenotypic feature of NSUN3-related mitochondrial disease that includes hypertrophic cardiomyopathy. This case report with literature review highlights the clinical importance of wobble base modifications in mitochondrial tRNA and their impact on cardiac function.
Cancer and dysregulated RNA modification
NSUN2, the enzyme responsible for m5C at the wobble position of tRNA-Leu(CAA), is overexpressed in several cancers and its activity can affect translational programs that support tumor growth. Although direct causal links require further study, the role of NSUN2 in tRNA modification suggests that GO:0002127 may contribute to cancer cell proteostasis.
Neurodevelopmental disorders
Defects in tRNA modification pathways, including those affecting wobble positions, have been associated with neurodevelopmental phenotypes. The intron-dependent m5C formation by NSUN2 is critical for proper tRNA function in neurons, and its disruption may contribute to neurological disease.

From tRNA wobble base cytosine methylation-Related Genes to Experimental Models

Research QuestionSuitable Model
Does NSUN2 loss affect global translation?NSUN2 knockout HEK293T cells followed by polysome profiling
Is the catalytic activity of NSUN2 required for tRNA stability?Point mutation (catalytic dead) knock-in of NSUN2
How does NSUN3 mutation cause cardiomyopathy?Knock-in of patient mutation in iPSC-derived cardiomyocytes
Can m5C at wobble position be dynamically reversed?Overexpression of ALKBH1 in cells with NSUN2-mediated m5C
What is the role of intron in m5C formation?Knockout of splicing factors combined with NSUN2 overexpression
Does NSUN2 overexpression alter cancer cell proteome?NSUN2 overexpression in cancer cell lines followed by proteomics

How to Study the tRNA wobble base cytosine methylation Process

MethodWhat It MeasuresTypical Application
RNA bisulfite sequencingm5C levels at single-base resolutionMapping wobble m5C in tRNAs
Ribo-seqRibosome occupancy and codon-specific translationAssessing translational fidelity upon NSUN2 loss
Polysome profilingGlobal translation efficiencyValidating NSUN2 knockout effects
Mass spectrometryProtein expression changesProteomic profiling of NSUN2-modulated cells
Chemical probingtRNA anticodon accessibilityStructural studies of wobble modifications
Enzymatic probingtRNA-synthetase interactionsStudying tRNA identity and modification
CRISPR knockoutGene function lossCreating NSUN2 or NSUN3 null cells
CRISPR knock-inPrecise mutation introductionModeling patient-specific NSUN3 mutations
RNA sequencing and m5C mapping
RNA-seq and specialized m5C detection methods (e.g., bisulfite sequencing, miCLIP) can map cytosine methylation at single-nucleotide resolution, including position 34 of tRNAs. These approaches quantify changes in m5C levels upon NSUN2 perturbation.
Ribosome profiling (Ribo-seq)
Ribo-seq measures ribosome occupancy on mRNAs and can reveal codon-specific translation defects when wobble methylation is lost. It is used to assess how GO:0002127 influences translational efficiency.
Proteomics and translational profiling
Mass spectrometry-based proteomics can detect global changes in protein synthesis and identify specific proteins whose expression depends on NSUN2-mediated m5C. This helps link the modification to cellular phenotypes.
Structural probing and chemical modification
Chemical and enzymatic probes, such as those used to study tRNA-synthetase interactions, can assess anticodon loop accessibility and modification status. These techniques provide structural insight into how m5C34 affects tRNA function.

How CRISPR Can Be Used to Study GO:0002127 tRNA wobble base cytosine methylation

Knockout

CRISPR knockout of NSUN2 or NSUN3 eliminates the enzymes responsible for wobble cytosine methylation, enabling studies of downstream effects on tRNA stability, translation, and cellular phenotypes. Such models are essential to establish causality for GO:0002127.

Point Mutation

Introducing catalytic-dead point mutations in NSUN2 (e.g., in the methyltransferase domain) via CRISPR knock-in allows separation of catalytic activity from scaffolding functions. This is critical to confirm that m5C formation is required for observed phenotypes.

Knock-in

Knock-in of patient-specific mutations, such as those found in NSUN3-related mitochondrial disease, creates isogenic models to study disease mechanisms and test therapeutic interventions. These models are valuable for understanding how wobble modification defects lead to cardiomyopathy.

Overexpression

CRISPR-mediated overexpression of NSUN2 or its catalytic mutants can reveal gain-of-function effects on translation and cell proliferation. Overexpression models are useful for studying cancers where NSUN2 is upregulated.

How EDITGENE Supports tRNA wobble base cytosine methylation Research

Researchers studying tRNA wobble base cytosine methylation-related genes often need to determine whether a candidate gene is causally involved in the modification pathway or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal studies, from gene knockout to precise point mutations and knock-in models, tailored to the specific needs of epitranscriptomics research.
Contact EDITGENE today to design your custom CRISPR model for tRNA wobble base cytosine methylation research.

Frequently Asked Questions About tRNA wobble base cytosine methylation

It is the post-transcriptional addition of a methyl group to the C5 position of cytosine 34 in the tRNA anticodon, forming m5C, as defined by GO:0002127.
The primary human gene is NSUN2, which catalyzes intron-dependent m5C formation in pre-tRNA-Leu(CAA); NSUN3 is involved in mitochondrial tRNA modifications linked to disease.
GO:0002127 modulates codon-anticodon pairing and translational fidelity by introducing m5C at the wobble position of tRNAs.
NSUN2 is the human tRNA:m5C methyltransferase responsible for m5C at position 34 of pre-tRNA-Leu(CAA).
It is studied using RNA bisulfite sequencing, Ribo-seq, mass spectrometry, and chemical probing, often combined with CRISPR knockout or knock-in models.
NSUN3-related mitochondrial disease can present with hypertrophic cardiomyopathy, and NSUN2 dysregulation is implicated in cancer and neurodevelopmental disorders.
Yes, demethylases such as ALKBH1 can reverse m5C modifications, suggesting dynamic regulation.
NSUN2 primarily modifies nuclear-encoded tRNAs like pre-tRNA-Leu(CAA), while NSUN3 modifies mitochondrial tRNAs and is associated with mitochondrial disease.
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable causal studies of NSUN2, NSUN3, and related genes.
It fine-tunes the interaction between tRNA anticodons and mRNA codons, affecting the speed and accuracy of protein synthesis.

Conclusion

GO:0002127, tRNA wobble base cytosine methylation, is a critical epitranscriptomic process that ensures translational fidelity through m5C modification at position 34 of tRNAs. The enzyme NSUN2 catalyzes this modification in an intron-dependent manner, and its dysfunction is linked to cancer and neurodevelopmental disorders, while NSUN3 mutations cause mitochondrial disease with hypertrophic cardiomyopathy. Continued research using CRISPR-based models and advanced RNA mapping techniques will further elucidate the mechanistic and clinical significance of this modification.

References

  1. 1. Şenol Ersak A et al.. 2026. Hypertrophic cardiomyopathy as a novel phenotypic feature of NSUN3-related mitochondrial disease: a case report with review of the literature.. J Pediatr Endocrinol Metab 39(4):372-380 PMID: 41725275
  2. 2. Brzezicha B et al.. 2006. Identification of human tRNA:m5C methyltransferase catalysing intron-dependent m5C formation in the first position of the anticodon of the pre-tRNA Leu (CAA).. Nucleic Acids Res 34(20):6034-43 PMID: 17071714
  3. 3. Pelka H et al.. 1986. Study of the interaction of Escherichia coli methionyl-tRNA synthetase with tRNAfMet using chemical and enzymatic probes.. Biochemistry 25(15):4450-6 PMID: 3092857
Contact Us
*
*
*
*
How did you hear about us: